These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 30885203)

  • 1. Altered bioavailability of epoxyeicosatrienoic acids is associated with conduit artery endothelial dysfunction in type 2 diabetic patients.
    Duflot T; Moreau-Grangé L; Roche C; Iacob M; Wils J; Rémy-Jouet I; Cailleux AF; Leuillier M; Renet S; Li D; Morisseau C; Lamoureux F; Richard V; Prévost G; Joannidès R; Bellien J
    Cardiovasc Diabetol; 2019 Mar; 18(1):35. PubMed ID: 30885203
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alteration in the availability of epoxyeicosatrienoic acids contributes with NO to the development of endothelial dysfunction in conduit arteries during aging.
    Wils J; Djerada Z; Roca F; Duflot T; Iacob M; Remy-Jouet I; Joannides R; Bellien J
    Atherosclerosis; 2018 Aug; 275():239-245. PubMed ID: 29980050
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epoxyeicosatrienoic acids contribute with altered nitric oxide and endothelin-1 pathways to conduit artery endothelial dysfunction in essential hypertension.
    Bellien J; Iacob M; Remy-Jouet I; Lucas D; Monteil C; Gutierrez L; Vendeville C; Dreano Y; Mercier A; Thuillez C; Joannides R
    Circulation; 2012 Mar; 125(10):1266-75. PubMed ID: 22412088
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epoxyeicosatrienoic and dihydroxyeicosatrienoic acids dilate human coronary arterioles via BK(Ca) channels: implications for soluble epoxide hydrolase inhibition.
    Larsen BT; Miura H; Hatoum OA; Campbell WB; Hammock BD; Zeldin DC; Falck JR; Gutterman DD
    Am J Physiol Heart Circ Physiol; 2006 Feb; 290(2):H491-9. PubMed ID: 16258029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impaired role of epoxyeicosatrienoic acids in the regulation of basal conduit artery diameter during essential hypertension.
    Bellien J; Remy-Jouet I; Iacob M; Blot E; Mercier A; Lucas D; Dreano Y; Gutierrez L; Donnadieu N; Thuillez C; Joannides R
    Hypertension; 2012 Dec; 60(6):1415-21. PubMed ID: 23090775
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epoxyeicosatrienoic acid pathway in human health and diseases.
    Bellien J; Joannides R
    J Cardiovasc Pharmacol; 2013 Mar; 61(3):188-96. PubMed ID: 23011468
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A sensitive LC-MS/MS method for the quantification of regioisomers of epoxyeicosatrienoic and dihydroxyeicosatrienoic acids in human plasma during endothelial stimulation.
    Duflot T; Pereira T; Roche C; Iacob M; Cardinael P; Hamza NE; Thuillez C; Compagnon P; Joannidès R; Lamoureux F; Bellien J
    Anal Bioanal Chem; 2017 Mar; 409(7):1845-1855. PubMed ID: 27981341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endothelium-dependent adaptation of arterial wall viscosity during blood flow increase is impaired in essential hypertension.
    Roca F; Bellien J; Iacob M; Joannides R
    Atherosclerosis; 2019 Jun; 285():102-107. PubMed ID: 31051413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early stage detection of conduit artery endothelial dysfunction in patients with type 1 diabetes.
    Bellien J; Costentin A; Dutheil-Maillochaud B; Iacob M; Kuhn JM; Thuillez C; Joannides R
    Diab Vasc Dis Res; 2010 Apr; 7(2):158-66. PubMed ID: 20382780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apolipoprotein B-48 as a determinant of endothelial function in obese subjects with type 2 diabetes mellitus: effect of fenofibrate treatment.
    Chan DC; Wong AT; Yamashita S; Watts GF
    Atherosclerosis; 2012 Apr; 221(2):484-9. PubMed ID: 22341868
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coenzyme Q(10) improves endothelial dysfunction of the brachial artery in Type II diabetes mellitus.
    Watts GF; Playford DA; Croft KD; Ward NC; Mori TA; Burke V
    Diabetologia; 2002 Mar; 45(3):420-6. PubMed ID: 11914748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of soluble epoxide hydrolase attenuates endothelial dysfunction in animal models of diabetes, obesity and hypertension.
    Zhang LN; Vincelette J; Chen D; Gless RD; Anandan SK; Rubanyi GM; Webb HK; MacIntyre DE; Wang YX
    Eur J Pharmacol; 2011 Mar; 654(1):68-74. PubMed ID: 21187082
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of cytochrome P450-derived eicosanoids in humans with stable atherosclerotic cardiovascular disease.
    Theken KN; Schuck RN; Edin ML; Tran B; Ellis K; Bass A; Lih FB; Tomer KB; Poloyac SM; Wu MC; Hinderliter AL; Zeldin DC; Stouffer GA; Lee CR
    Atherosclerosis; 2012 Jun; 222(2):530-6. PubMed ID: 22503544
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hand skin heating: a new method for the evaluation of conduit artery endothelial function in insulin-dependent diabetic patients].
    Bellien J; Joannidès R; Costentin A; Dutheil-Maillochaud B; Iacob M; Kuhn JM; Thuillez C
    Arch Mal Coeur Vaiss; 2004; 97(7-8):744-8. PubMed ID: 15506058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic ACE inhibition enhances the endothelial control of arterial mechanics and flow-dependent vasodilatation in heart failure.
    Joannides R; Bizet-Nafeh C; Costentin A; Iacob M; Derumeaux G; Cribier A; Thuillez C
    Hypertension; 2001 Dec; 38(6):1446-50. PubMed ID: 11751733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of Cytochrome p450 and Soluble Epoxide Hydrolase Enzymes and Their Associated Metabolites in the Pathogenesis of Diabetic Cardiomyopathy.
    Maayah ZH; McGinn E; Al Batran R; Gopal K; Ussher JR; El-Kadi AOS
    J Cardiovasc Pharmacol; 2019 Sep; 74(3):235-245. PubMed ID: 31306370
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diabetic CVD--soluble epoxide hydrolase as a target.
    Lorthioir A; Guerrot D; Joannides R; Bellien J
    Cardiovasc Hematol Agents Med Chem; 2012 Sep; 10(3):212-22. PubMed ID: 22632263
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic syndrome individuals with and without type 2 diabetes mellitus present generalized vascular dysfunction: cross-sectional study.
    Walther G; Obert P; Dutheil F; Chapier R; Lesourd B; Naughton G; Courteix D; Vinet A
    Arterioscler Thromb Vasc Biol; 2015 Apr; 35(4):1022-9. PubMed ID: 25657309
    [TBL] [Abstract][Full Text] [Related]  

  • 19. EETs/sEH in diabetes and obesity-induced cardiovascular diseases.
    Huang H; Weng J; Wang MH
    Prostaglandins Other Lipid Mediat; 2016 Sep; 125():80-9. PubMed ID: 27184755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction between P450 eicosanoids and nitric oxide in the control of arterial tone in mice.
    Hercule HC; Schunck WH; Gross V; Seringer J; Leung FP; Weldon SM; da Costa Goncalves ACh; Huang Y; Luft FC; Gollasch M
    Arterioscler Thromb Vasc Biol; 2009 Jan; 29(1):54-60. PubMed ID: 18927469
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.